Explore

TrendlineTrendline
Anywhere Active Launches Virtual Fitness Platform for Public Libraries and Community Organizations Nationwide

Anywhere Active Launches Virtual Fitness Platform for Public Libraries and Community Organizations Nationwide

Anywhere Active Launches Virtual Fitness Platform for Public Libraries and Community Organizations Nationwide
Rapid ReadRapid Read
41 States Adopt Medicaid Expansion Under Affordable Care Act, 10 States Yet to Expand

41 States Adopt Medicaid Expansion Under Affordable Care Act, 10 States Yet to Expand

As of the latest tracking, 41 states, including the District of Columbia, have adopted the Medicaid expansion provision of the Affordable Care Act (ACA). This expansion extends Medicaid coverage to nearly all adults whose incomes are up to 138% of the Federal Poverty Level, which translates to $21,597 for an individual in 2025. States that adopt this expansion receive an enhanced federal matching rate (FMAP) for their expansion populations, providing significant financial incentives. Conversely, 10 states have not yet adopted the ACA's Medicaid expansion. The status of each state is continuously monitored and analyzed by KFF, reflecting legislative actions, executive orders, and voter-led initiatives related to the expansion. This ongoing process highlights the varying approaches states are taking regarding healthcare access and federal funding opportunities under the ACA.
TrendlineTrendline
Eli Lilly, Novo Nordisk, and Pfizer Intensify Competition in China's Weight-Loss Drug Market at CIIE

Eli Lilly, Novo Nordisk, and Pfizer Intensify Competition in China's Weight-Loss Drug Market at CIIE

Eli Lilly, Novo Nordisk, and Pfizer Intensify Competition in China's Weight-Loss Drug Market at CIIE
Rapid ReadRapid Read
GLP-1 Medications Show Promise in Menopause Weight Management, But Specific Research Gaps Remain

GLP-1 Medications Show Promise in Menopause Weight Management, But Specific Research Gaps Remain

GLP-1 medications, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are gaining attention for their potential role in managing weight during menopause, according to Acibadem International. While no randomized trials have specifically studied GLP-1 medicines in menopausal women, subgroup data from broader trials suggest that women over 50 experience similar percentages of weight loss as younger adults. For instance, pivotal trials showed average weight loss of 15% to 21% over 68-72 weeks. An observational analysis in 2024 indicated that postmenopausal women taking semaglutide alongside hormone therapy lost more weight (16%) than those on semaglutide alone (12%). However, this finding is considered weak to moderate evidence due to the study's observational nature and small sample size. GLP-1s primarily work by reducing appetite, slowing stomach emptying, and regulating blood sugar, rather than directly affecting menopausal hormones.
TrendlineTrendline
Third-Party Administrators Streamline Self-Funded Health Plans for U.S. Employers

Third-Party Administrators Streamline Self-Funded Health Plans for U.S. Employers

Third-Party Administrators Streamline Self-Funded Health Plans for U.S. Employers
Rapid ReadRapid Read
Ozempic and Saxenda Differ in Licensing and Dosing for Diabetes and Weight Management

Ozempic and Saxenda Differ in Licensing and Dosing for Diabetes and Weight Management

Ozempic (semaglutide) and Saxenda (liraglutide) are both GLP-1 receptor agonists used in the U.S., but they have distinct licenses and dosing schedules, according to The London Obesity Clinic. Ozempic is primarily licensed for the treatment of type 2 diabetes, while Saxenda is licensed for weight management in eligible individuals alongside dietary changes and physical activity. Although both medications work by mimicking the GLP-1 hormone to regulate appetite and blood sugar, they are not interchangeable. Ozempic is administered as a weekly injection because semaglutide remains active longer, whereas Saxenda requires daily injections. The clinic emphasizes that using Ozempic for weight management without a type 2 diabetes diagnosis is considered 'off-label' prescribing, requiring specific clinical justification and discussion. Wegovy, which also contains semaglutide, is specifically licensed for weight management.
Rapid ReadRapid Read
GLP-1 Medications Require Special Considerations for Adults Over 65, UNC Health Geriatrician Advises

GLP-1 Medications Require Special Considerations for Adults Over 65, UNC Health Geriatrician Advises

Adults aged 65 and older considering GLP-1 medications like Ozempic and Zepbound for weight management and diabetes control need to be aware of specific considerations, according to UNC Health geriatrician John Batsis, MD. While these medications offer significant benefits in weight loss and blood sugar regulation, most initial trials were conducted on adults younger than 65, meaning there is less specific data for older populations. Dr. Batsis highlights that while the benefits of weight loss and improved blood sugar control remain, older adults face different risks. These include increased susceptibility to gastrointestinal side effects like nausea and constipation, which can lead to dehydration. Additionally, rapid weight loss in older adults can result in a more pronounced loss of muscle and bone mass, potentially increasing the risk of osteoporosis, frailty, falls, and permanent disability. He advises a 'low and slow' approach to dosing and emphasizes the importance of a balanced diet, regular exercis...
ReutersReuters
US hospitals brace for tougher 2027 as coverage losses and Medicaid cuts loom

US hospitals brace for tougher 2027 as coverage losses and Medicaid cuts loom

By Christy Santhosh and Kamal Choudhury Nov 5 (Reuters) - US hospital operators are bracing for revenue pressure from more patients losing insurance coverage from the Affordable Care Act, a potential drop in government aid for treating Medicaid patients and deeper reimbursement cuts beginning in
USA TodayUSA Today
Pittsburgh restaurants offer Veterans Day food freebies, discounts

Pittsburgh restaurants offer Veterans Day food freebies, discounts

Restaurants in the Pittsburgh area will offer freebies and discounts on Veterans Day for veterans and active service members.
Rapid ReadRapid Read
GLP-1 Medications Influence U.S. Home Design and Waste Management Practices

GLP-1 Medications Influence U.S. Home Design and Waste Management Practices

The increasing use of GLP-1 medications in the U.S. is beginning to influence home design, particularly in kitchens and bathrooms, and is raising concerns about household waste management. According to an analysis by PwC, 21% of U.S. households currently include a GLP-1 user, up from 9% in January 2025. This shift is leading to trends like 'hidden kitchens' and more compact, efficient layouts, as users report reduced 'food noise' and a decreased need for large food storage and preparation areas. Concurrently, New York City has seen a significant increase in needlestick injuries among sanitation workers, tripling since 2023, with the Department of Sanitation identifying injectable medications, including GLP-1s, as a possible contributing factor. The city plans to more than double fines for improperly discarded household medical waste.
TrendlineTrendline
PepsiCo Strengthens Snack Pricing Strategy to Drive Volume Growth in North America

PepsiCo Strengthens Snack Pricing Strategy to Drive Volume Growth in North America

PepsiCo Strengthens Snack Pricing Strategy to Drive Volume Growth in North America
TrendlineTrendline
Cohere Health's AI Pre-Payment Review Saves Medicare Advantage Client Over $10 Million

Cohere Health's AI Pre-Payment Review Saves Medicare Advantage Client Over $10 Million

Cohere Health's AI Pre-Payment Review Saves Medicare Advantage Client Over $10 Million